Floatz logo

IMMUNOGLOBULIN G1, ANTI-(HUMAN PLATELET-DERIVED GROWTH FACTOR RECEPTOR .ALPHA.) (HUMAN MONOCLONAL 3G3 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 3G3 .KAPPA.-CHAIN, DIMER

Neoplasm

Eli Lilly and Companymonoclonal_antibodyPhase 1Dormant
CCC
50/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
89/ 100

Competitive context

928 Active assets in the Neoplasm cohort.

Asset / SponsorPhaseRating
PANITUMUMAB
Astellas Pharma Inc
Phase 2BBB
GRANULOCYTE COLONY-STIMULATING FACTOR LENOGRASTIM
Sanofi
Phase 4BB
Inno-206
The First Affiliated Hospital of Soochow University
Phase 2/3BB
DINITROGEN MONOXIDE
Medical College of Wisconsin
Phase 4BB
Glycopyrrolate
Medical College of Wisconsin
Phase 4BB

View all 50 →

Same molecule, other indications

IMMUNOGLOBULIN G1, ANTI-(HUMAN PLATELET-DERIVED GROWTH FACTOR RECEPTOR .ALPHA.) (HUMAN MONOCLONAL 3G3 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 3G3 .KAPPA.-CHAIN, DIMER is also rated in:

adult glioblastomaDormant
B
Indicative ·
57 / 100
View asset →
ovarian neoplasmDormant
CCC
Indicative ·
54 / 100
View asset →
prostate cancerDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →